CARGO Therapeutics Statistics

Total Valuation

CRGX has a market cap or net worth of $895.14 million. The enterprise value is $479.80 million.

Market Cap	895.14M
Enterprise Value	479.80M

Important Dates

The next estimated earnings date is Thursday, November 21, 2024, after market close.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	n/a

Share Statistics

CRGX has 45.90 million shares outstanding. The number of shares has increased by 4,665.21% in one year.

Shares Outstanding	45.90M
Shares Change (YoY)	+4,665.21%
Shares Change (QoQ)	+5.73%
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	73.18%
Float	30.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.05
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.96, with a Debt / Equity ratio of 0.06.

Current Ratio	16.96
Quick Ratio	16.88
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.22% and return on invested capital (ROIC) is -38.53%.

Return on Equity (ROE)	-63.22%
Return on Assets (ROA)	-34.92%
Return on Capital (ROIC)	-38.53%
Revenue Per Employee	n/a
Profits Per Employee	-$1.27M
Employee Count	116
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	20.08
200-Day Moving Average	20.15
Relative Strength Index (RSI)	45.01
Average Volume (20 Days)	163,871

Short Selling Information

The latest short interest is 5.43 million, so 11.83% of the outstanding shares have been sold short.

Short Interest	5.43M
Short Previous Month	5.07M
Short % of Shares Out	11.83%
Short % of Float	17.57%
Short Ratio (days to cover)	13.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-153.79M
Pretax Income	n/a
Net Income	-147.71M
EBITDA	-151.63M
EBIT	-153.79M
Earnings Per Share (EPS)	-$5.53

Full Income Statement

Balance Sheet

The company has $443.48 million in cash and $28.14 million in debt, giving a net cash position of $415.34 million or $9.05 per share.

Cash & Cash Equivalents	443.48M
Total Debt	28.14M
Net Cash	415.34M
Net Cash Per Share	$9.05
Equity (Book Value)	436.10M
Book Value Per Share	9.51
Working Capital	421.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$117.43 million and capital expenditures -$8.98 million, giving a free cash flow of -$126.40 million.

Operating Cash Flow	-117.43M
Capital Expenditures	-8.98M
Free Cash Flow	-126.40M
FCF Per Share	-$2.75

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRGX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4,665.21%
Shareholder Yield	-4,665.21%
Earnings Yield	-16.50%
FCF Yield	-14.12%

Analyst Forecast

The average price target for CRGX is $30.33, which is 55.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.33
Price Target Difference	55.54%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2